Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

14.860
+0.1200.81%
Volume:6.15M
Turnover:91.19M
Market Cap:46.38B
PE:6.49
High:14.920
Open:14.750
Low:14.640
Close:14.740
52wk High:21.258
52wk Low:14.600
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:1.72
T/O Rate:0.46%
Dividend:0.79
Dividend Rate:5.32%
EPS(LYR):2.290
ROE:8.04%
ROA:2.55%
PB:0.47
PE(LYR):6.49
PS:0.07

Loading ...

Sinopharm Group (SEHK:1099) Stock Drifts As Stable Earnings Meet Thin Margins

Simply Wall St.
·
Aug 25

Citigroup Cuts Sinopharm Target Price to HK$20.4 Amid Weak First-Half Results

Stock News
·
Aug 25

Sinopharm Group Stock Falls 1.9% in Hong Kong

Dow Jones
·
Aug 24

Sinopharm Group's Profit Declines 2% in H1

MT Newswires Live
·
Aug 24

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Reuters
·
Aug 24

Sinopharm Group’s 1H26 Results: Revenue Slips 1.1%, Retail Pharmacy Shines Amid Mixed Segment Performance

Bulletin Express
·
Aug 24

Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors

Reuters
·
Aug 24

Sinopharm Group H1 Revenue RMB 282,799.6 Million

THOMSON REUTERS
·
Aug 24

Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion

Reuters
·
Aug 24

Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan

MT Newswires Live
·
Aug 20

Sinopharm Group Sells 42.19% of Guorui Pharmaceutical; SSPC to Assume Control in RMB406.36 Million Connected Deal

Bulletin Express
·
Aug 19

Sinopharm Group and Partners to Divest 51% Stake in Guorui Pharma for RMB 406 Million

Stock News
·
Aug 19

Sinopharm Sells 30.13% Stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 Million

Reuters
·
Aug 19

Sinopharm Group - to Sell 30.13% Stake in China National Medicines Guorui Pharmaceutical for Rmb240.0731 Mln

THOMSON REUTERS
·
Aug 19

Sinopharm (CNCM LTD) H1 2026 Revenue Up 4.27% to RMB 26.73 Billion; Net Profit Falls 7.25%

Bulletin Express
·
Aug 19

SINOPHARM Reports Mid-Year Results for Its Medical Device Unit

Stock News
·
Aug 19

China National Medical Device, Sinopharm Subsidiary, Posts H1 Operating Profit Down 12.34% to RMB 599.37 Million

Reuters
·
Aug 19

Sinopharm Announces Changes to Board Committee Composition Effective 18 August 2026

Bulletin Express
·
Aug 18

Sinopharm Appoints Yang Binghua to Board Strategy and Investment Committee

Reuters
·
Aug 18

Sinopharm Group - China National Accord Medicines H1 2026 Net Profit Attributable Rmb606.2 Mln, Down 8.97% Y/Y

THOMSON REUTERS
·
Aug 17